Recently visited unit
name Price (yuan) Rise and fall
The following are popular stocks
Please check the self selected shares first
join remind View in APP

Hengrui Pharmaceutical (600276.SH)

Questioning stocks
@change@
@changeP@
@now@
Limit: @ up_limit@
Limit: @ down_limit@
Suspension
@date@ @time@
Temporary suspension
Today: @open@ Volume: @volume@ Amplitude: @swing@
Maximum: @high@ Turnover: @amount@ turnover rate: @turnover@
Minimum: @low@ Total Market Value: @fixTotalShare@ P/B ratio: @pb@
Received yesterday: @preClose@ Circulation value: @cvs@ P/E ratio TTM @pe@
Total share capital: @zgb@ Circulating shares: @ltgb@
Information mine:
    The browser version is too low to view the multi null inversion

    Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox Google

    Time-sharing
    Day K
    Week K
    Month K
    K line
    Reinstatement K line
    Technical drawings
    Also concerned:
      5th gear disc opening
      Live broadcast of famous teachers
      Commission ratio -- Abandonment --
      Selling ⑤ -- --
      Sell ④ -- --
      Selling ③ -- --
      Sell ② -- --
      Selling ① -- --
      deal --
      Buy ① -- --
      Buy ② -- --
      Buy ③ -- --
      Buy ④ -- --
      Buy ⑤ -- --
      Outer disc -- Inner disc --

      In case of a key big order, the main force may**

      Quickly use level2 to view details>
      time Price (yuan) Measurement (hand) nature
      time Price (yuan) Measurement (hand) nature
      Transaction price (yuan) Trading volume (hand) Proportion (%)
      time Transaction price (yuan) Trading volume (hand)
      Product entry: Sina Finance APP - Stocks - Investment Research Report
      Product entrance: Sina Finance APP - stock - free question
      Product entrance: Sina Finance APP - stock - free question
      Main and retail investors' capital flow
      Main buy Main sales Purchase by retail investors Retail sales
      Amount (10000 yuan) @mainIn@ @mainOut@ @retailIn@ @retailOut@
      proportion @mainInP@ @mainOutP@ @retailInP@ @retailOutP@
      Loose bill
      Small order
      Large order
      Extra large order
      Net inflow of classified funds
      Loose bill Small order Large order Extra large order
      Net inflow (10000 yuan) @r3_r_in@ @r2_r_in@ @r1_r_in@ @r0_r_in@
      Proportion in the flow board @r3_p_svs@ @r2_p_svs@ @r1_p_svs@ @r0_p_svs@
      Proportion in turnover rate @r3_p_turnover@ @r2_p_turnover@ @r1_p_turnover@ @r0_p_turnover@
      title click reply Final reply

      Company research

      Hot data

      more
      Adjacent ranking
      Top 10 in the industry

      Financial ratios

      more
      Adjacent ranking
      Top 10 in the industry

      Investment rating of research institutions

      more

      In the last 60 days Hengrui Pharmaceutical (sh600276) rating was released in three research reports, and the comprehensive rating is as follows:

      Hot columns

      Industry comparison

      name Price (yuan)

      corporate name:

      Jiangsu Hengrui Pharmaceutical Co., Ltd

      Main business:

      Development, manufacturing and marketing of chemical raw materials, tablets, injections, capsules, powder injections and other western medicine preparations

      Telephone: 0518-81220983,021-61053323

      Fax: 0518-85453845,021-61063801

      Date of establishment: 1997-04-28

      Listing date: 2000-10-18

      Legal representative: Sun Yaoyang

      general manager: Dai Hongbin

      Registered capital: 6379 million yuan

      Issue price: 11.98 yuan

      Latest total share capital: 6379002274 shares

      Latest outstanding shares: 10000 shares

      Segment: Shanghai and Shenzhen A-share Shanghai A-share Shangzheng Medicine Shanghai Stock Exchange Index Coastal development Insurance position Fund position Equity incentive Pharmaceuticals Shanghai Stock Connect Shanghai Stock Connect Margin trading

      2024-03
      2023-12
      2023-09
      2023-06
      2023-03
      Earnings per share 0.2146 yuan 0.6745 yuan RMB 0.5446 0.3619 yuan 0.1942 yuan
      net asset value per share 6.5643 yuan 6.3436 yuan 6.2137 yuan 6.0920 yuan 6.0968 yuan
      Net operating cash flow per share 0.1967 yuan 1.1983 yuan 0.6755 yuan 0.4508 yuan 0.0335 yuan
      Return on net assets 3.27% 10.63% 8.76% 5.94% 3.19%
      Undistributed profit per share 4.7298 yuan 4.5152 yuan 4.3854 yuan 4.2027 yuan 4.1949 yuan
      Capital reserve per share 0.4879 yuan 0.4793 yuan 0.4971 yuan 0.4892 yuan 0.4813 yuan
      Date of announcement Allocation scheme
      2023-06-02 10 pai 1.6 yuan
      2022-06-29 10 pai 1.6 yuan
      2021-06-04 2 shares for 10 yuan
      2020-05-19 2 shares for 2 shares for 2 yuan
      2019-03-21 RMB 2.2 for 10 shares, 2 shares for free
      2024-05
      2024-03
      2023-12
      Name of shareholders Shareholding (%) Increase or decrease
      Jiangsu Hengrui Medicine Collection twenty-four point one one three Unchanged
      Tibet Dayuan Enterprise Management Co., Ltd fourteen point nine three six Unchanged
      HKSCC has six point four nine one Overweight
      China's pharmaceutical investment has three point seven eight four Unchanged
      Qingdao Bosentai Investment Co., Ltd two point eight six five Unchanged
      Lianyungang Financial Control Co., Ltd one point eight three seven Overweight
      China Securities Finance Co., Ltd one point four nine six Unchanged
      Industrial and Commercial Bank of China shares one point two six four reduce one's shares in a listed company
      Industrial and Commercial Bank of China - one point one two five reduce one's shares in a listed company
      China Construction Bank Co., Ltd one point zero one eight Overweight

      Shareholding ratio of circulating shareholders



      user name:
      Password: